相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PepQuery2 democratizes public MS proteomics data for rapid peptide searching
Bo Wen et al.
NATURE COMMUNICATIONS (2023)
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Yifat Geffen et al.
CELL (2023)
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Yize Li et al.
CELL (2023)
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
Liangqing Dong et al.
CANCER CELL (2022)
Immunopeptidomic analyses of colorectal cancers with and without microsatellite instability
Jenna Cleyle et al.
MOLECULAR & CELLULAR PROTEOMICS (2022)
Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways
Yiqun Zhang et al.
NATURE COMMUNICATIONS (2022)
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population
Yuanyuan Qu et al.
NATURE COMMUNICATIONS (2022)
Integrated proteogenomic characterization of medullary thyroid carcinoma
Xiao Shi et al.
CELL DISCOVERY (2022)
OmicsEV: a tool for comprehensive quality evaluation of omics data tables
Bo Wen et al.
BIOINFORMATICS (2022)
dbPepVar: A Novel Cancer Proteogenomics Database
Lucas Marques da Cunha et al.
IEEE ACCESS (2022)
Cancer proteogenomics: current impact and future prospects
D. R. Mani et al.
NATURE REVIEWS CANCER (2022)
Enhanced protein isoform characterization through long-read proteogenomics
Rachel M. Miller et al.
GENOME BIOLOGY (2022)
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
Chen Huang et al.
CANCER CELL (2021)
Proteogenomic and metabolomic characterization of human glioblastoma
Liang-Bo Wang et al.
CANCER CELL (2021)
Simplified and Unified Access to Cancer Proteogenomic Data
Caleb M. Lindgren et al.
JOURNAL OF PROTEOME RESEARCH (2021)
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Brian D. Lehmann et al.
NATURE COMMUNICATIONS (2021)
The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment
Henry Rodriguez et al.
CELL (2021)
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence Variants
Amol Prakash et al.
CANCERS (2021)
Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigens
Rong Xiang et al.
COMMUNICATIONS BIOLOGY (2021)
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Liwei Cao et al.
CELL (2021)
A proteogenomic portrait of lung squamous cell carcinoma
Shankha Satpathy et al.
CELL (2021)
PANOPLY: a cloud-based platform for automated and reproducible proteogenomic data analysis
D. R. Mani et al.
NATURE METHODS (2021)
Recent Advances in Mass Spectrometry-Based Glycomic and Glycoproteomic Studies of Pancreatic Diseases
Dylan Nicholas Tabang et al.
FRONTIERS IN CHEMISTRY (2021)
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer
Dongqing Huang et al.
CELL REPORTS MEDICINE (2021)
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
Janne Lehtio et al.
NATURE CANCER (2021)
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma (vol 179, pg 964, 2019)
David J. Clark et al.
CELL (2020)
Proteogenomic Characterization of Endometrial Carcinoma
Yongchao Dou et al.
CELL (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Interpreting pathways to discover cancer driver genes with Moonlight
Antonio Colaprico et al.
NATURE COMMUNICATIONS (2020)
Rapid and site-specific deep phosphoproteome profiling by data-independent acquisition without the need for spectral libraries
Dorte B. Bekker-Jensen et al.
NATURE COMMUNICATIONS (2020)
Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis
Bo Wen et al.
NATURE COMMUNICATIONS (2020)
Identification of a protein signature for predicting overall survival of hepatocellular carcinoma: a study based on data mining
Zeng-hong Wu et al.
BMC CANCER (2020)
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Michael A. Gillette et al.
CELL (2020)
Integrative Proteomic Characterization of Human Lung Adenocarcinoma
Jun-Yu Xu et al.
CELL (2020)
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression
Yi-Ju Chen et al.
CELL (2020)
ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies
Anna Pamela Calinawan et al.
PROTEOMICS (2020)
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
Yingwei Hu et al.
CELL REPORTS (2020)
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Francesca Petralia et al.
CELL (2020)
Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer
Jianbo Pan et al.
NATURE COMMUNICATIONS (2020)
Urinary glycoproteins associated with aggressive prostate cancer
Mingming Dong et al.
THERANOSTICS (2020)
SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma
Jinming Zhao et al.
FRONTIERS IN GENETICS (2020)
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Karsten Krug et al.
CELL (2020)
Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability
Jason E. McDermott et al.
CELL REPORTS MEDICINE (2020)
Development of cancer prognostic signature based on pan-cancer proteomics
Weiguo Huang et al.
BIOENGINEERED (2020)
PDV: an integrative proteomics data viewer
Kai Li et al.
BIOINFORMATICS (2019)
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Suhas Vasaikar et al.
CELL (2019)
Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer
Xiaohui Zhan et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal
Pamela Wu et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
FusionPro, a Versatile Proteogenomic Tool for Identification of Novel Fusion Transcripts and Their Potential Translation Products in Cancer Cells
Chae-Yeon Kim et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Qiang Gao et al.
CELL (2019)
Proteogenomic Characterization of Human Early-Onset Gastric Cancer
Dong-Gi Mun et al.
CANCER CELL (2019)
PepQuery enables fast, accurate, and convenient proteomic validation of novel genomic alterations
Bo Wen et al.
GENOME RESEARCH (2019)
Clinical potential of mass spectrometry-based proteogenomics
Bing Zhang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer
Mengsha Tong et al.
EBIOMEDICINE (2019)
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
Fengju Chen et al.
NATURE COMMUNICATIONS (2019)
Emerging roles of lncRNAs in the post-transcriptional regulation in cancer
Rong-Zhang He et al.
GENES & DISEASES (2019)
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Suhas V. Vasaikar et al.
NUCLEIC ACIDS RESEARCH (2018)
A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer
Xinxin Peng et al.
CANCER CELL (2018)
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding et al.
CELL (2018)
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Kyle Ellrott et al.
CELL SYSTEMS (2018)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Andre Kahles et al.
CANCER CELL (2018)
Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival
Wei Tang et al.
GENOME MEDICINE (2018)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
Can we predict protein from mRNA levels?
Nikolaus Fortelny et al.
NATURE (2017)
The Functional Impact of Alternative Splicing in Cancer
Hector Climente-Gonzalez et al.
CELL REPORTS (2017)
Widespread Post-transcriptional Attenuation of Genomic Copy-Number Variation in Cancer
Emanuel Goncalves et al.
CELL SYSTEMS (2017)
A Compendium of Co-regulated Protein Complexes in Breast Cancer Reveals Collateral Loss Events
Colm J. Ryan et al.
CELL SYSTEMS (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens
Anna Polyakova et al.
EXPERT REVIEW OF PROTEOMICS (2015)
Next-generation analysis of gene expression regulation - comparing the roles of synthesis and degradation
Joel McManus et al.
MOLECULAR BIOSYSTEMS (2015)
Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection
Adam D. Ewing et al.
NATURE METHODS (2015)
The utility of protein and mRNA correlation
Samuel H. Payne
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Uncovering Hidden Layers of Cell Cycle Regulation through Integrative Multi-omic Analysis
Ranen Aviner et al.
PLOS GENETICS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels
Philipp Mertins et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang et al.
NATURE (2014)
Onco-proteogenomics: cancer proteomics joins forces with genomics
Javier A. Alfaro et al.
NATURE METHODS (2014)
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
Ying Zhang et al.
CLINICAL PROTEOMICS (2014)
Translation Regulation as a Therapeutic Target in Cancer
Michal Grzmil et al.
CANCER RESEARCH (2012)
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Christine Vogel et al.
NATURE REVIEWS GENETICS (2012)
Deep proteome and transcriptome mapping of a human cancer cell line
Nagarjuna Nagaraj et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome
Keiichi Hatakeyama et al.
PROTEOMICS (2011)
Cancer-associated regulation of alternative splicing
Julian P. Venables et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
